Overcoming the Barrier of the Respiratory Epithelium during Canine Distemper Virus Infection.
air-liquid interface
canine distemper virus
cell-to-cell transmission
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
22 02 2022
22 02 2022
Historique:
entrez:
18
1
2022
pubmed:
19
1
2022
medline:
3
3
2023
Statut:
ppublish
Résumé
Canine distemper virus (CDV) is a highly contagious pathogen and is known to enter the host via the respiratory tract and disseminate to various organs. Current hypotheses speculate that CDV uses the homologous cellular receptors of measles virus (MeV), SLAM and nectin-4, to initiate the infection process. For validation, here, we established the well-differentiated air-liquid interface (ALI) culture model from primary canine tracheal airway epithelial cells. By applying the green fluorescent protein (GFP)-expressing CDV vaccine strain and recombinant wild-type viruses, we show that cell-free virus infects the airway epithelium mainly via the paracellular route and only after prior disruption of tight junctions by pretreatment with EGTA; this infection was related to nectin-4 but not to SLAM. Remarkably, when CDV-preinfected DH82 cells were cocultured on the basolateral side of canine ALI cultures grown on filter supports with a 1.0-μm pore size, cell-associated CDV could be transmitted via cell-to-cell contact from immunocytes to airway epithelial cultures. Finally, we observed that canine ALI cultures formed syncytia and started to release cell-free infectious viral particles from the apical surface following treatment with an inhibitor of the JAK/STAT signaling pathway (ruxolitinib). Our findings show that CDV can overcome the epithelial barrier through different strategies, including infection via immunocyte-mediated transmission and direct infection via the paracellular route when tight junctions are disrupted. Our established model can be adapted to other animals for studying the transmission routes and the pathogenicity of other morbilliviruses.
Identifiants
pubmed: 35038920
doi: 10.1128/mbio.03043-21
pmc: PMC8764546
doi:
Substances chimiques
Nectins
0
Egtazic Acid
526U7A2651
Receptors, Cell Surface
0
Cell Adhesion Molecules
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0304321Références
Viruses. 2016 Sep 20;8(9):
pubmed: 27657109
Viruses. 2019 Sep 25;11(10):
pubmed: 31557833
J Virol. 2001 May;75(10):4499-505
pubmed: 11312320
mBio. 2019 May 7;10(3):
pubmed: 31064833
J Virol. 2007 Apr;81(8):4158-65
pubmed: 17267508
One Health. 2015 Sep 13;1:49-59
pubmed: 28616465
J Cell Mol Med. 2017 Apr;21(4):816-830
pubmed: 27860224
Acta Neuropathol. 1996 Sep;92(3):273-80
pubmed: 8870829
Viral Immunol. 2002;15(3):493-505
pubmed: 12479398
Viruses. 2016 Oct 11;8(10):
pubmed: 27727184
J Wildl Dis. 1981 Jan;17(1):17-22
pubmed: 6265659
Sci Rep. 2016 May 27;6:26748
pubmed: 27229328
Int J Paleopathol. 2019 Mar;24:266-278
pubmed: 30743216
J Virol. 2014 Apr;88(8):4423-33
pubmed: 24501402
J Virol. 2001 Jul;75(13):5842-50
pubmed: 11390585
J Virol. 2012 Apr;86(7):3658-66
pubmed: 22278252
J Virol. 2014 Dec;88(24):14161-71
pubmed: 25275122
J Pathol. 2015 Jan;235(2):253-65
pubmed: 25294240
Nat Struct Mol Biol. 2012 Sep;19(9):906-15
pubmed: 22902367
Vet J. 2009 Oct;182(1):100-7
pubmed: 18684651
mBio. 2019 Nov 26;10(6):
pubmed: 31772054
Viruses. 2014 Jun 02;6(6):2268-86
pubmed: 24892636
J Immunol. 2007 Nov 1;179(9):6123-33
pubmed: 17947687
Vet Immunol Immunopathol. 2015 Jan 15;163(1-2):86-92
pubmed: 25534080
PLoS Pathog. 2021 Aug 12;17(8):e1009458
pubmed: 34383863
J Cell Sci. 2014 Mar 1;127(Pt 5):1052-1064
pubmed: 24424029
J Cell Sci. 2015 Feb 1;128(3):431-9
pubmed: 26046138
PLoS Pathog. 2018 Jun 28;14(6):e1007015
pubmed: 29953542
PLoS Pathog. 2017 May 8;13(5):e1006371
pubmed: 28481926
Am J Vet Res. 1977 Dec;38(12):1919-22
pubmed: 304324
PLoS One. 2014 Apr 25;9(4):e96121
pubmed: 24769532
J Virol. 2001 Jul;75(14):6418-27
pubmed: 11413309
Curr Opin Virol. 2012 Jun;2(3):248-55
pubmed: 22483507
Front Vet Sci. 2021 Mar 19;8:619759
pubmed: 33829052
Viruses. 2016 Jul 28;8(8):
pubmed: 27483301
Nat Struct Mol Biol. 2013 Jan;20(1):67-72
pubmed: 23202587
J Virol. 2018 Jul 17;92(15):
pubmed: 29793948
Vet Microbiol. 1996 Mar;49(1-2):147-52
pubmed: 8861651
PLoS Pathog. 2016 Sep 28;12(9):e1005922
pubmed: 27683250
Zentralbl Veterinarmed B. 1999 Jun;46(5):301-10
pubmed: 10416364
PLoS One. 2016 Dec 2;11(12):e0167517
pubmed: 27911942
J Virol. 2006 Jun;80(12):6084-92
pubmed: 16731947
Virol J. 2019 Mar 7;16(1):30
pubmed: 30845967
PLoS Pathog. 2011 Aug;7(8):e1002240
pubmed: 21901103
Nature. 1988 Sep 29;335(6189):403-4
pubmed: 3419515
Virology. 2014 Apr;454-455:109-17
pubmed: 24725937
Front Microbiol. 2012 Mar 01;3:75
pubmed: 22403577
PLoS Pathog. 2011 Jan 27;7(1):e1001263
pubmed: 21304593
Viruses. 2020 Mar 20;12(3):
pubmed: 32244946
Sci Rep. 2016 Dec 22;6:39668
pubmed: 28004801
J Virol. 2011 Dec;85(24):12855-66
pubmed: 21994464
J Virol. 2010 Jul;84(13):6328-43
pubmed: 20427537
Acta Neuropathol. 2005 Oct;110(4):369-82
pubmed: 16133545
Viruses. 2019 Oct 14;11(10):
pubmed: 31615092
Nature. 1996 Feb 1;379(6564):441-5
pubmed: 8559247
J Virol. 2014 Mar;88(5):2941-50
pubmed: 24371065
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14216-21
pubmed: 15377791
J Cell Mol Med. 2020 Aug;24(16):9332-9348
pubmed: 32627957
Vet Res. 2014 Feb 18;45:20
pubmed: 24548739
Viral Immunol. 2008 Dec;21(4):401-10
pubmed: 19115929
PLoS Pathog. 2016 Dec 7;12(12):e1006062
pubmed: 27926942
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):
pubmed: 33836570
Nature. 2011 Nov 02;480(7378):530-3
pubmed: 22048310
Front Immunol. 2019 Jun 05;10:1294
pubmed: 31231395
J Virol. 2016 Jul 11;90(15):6808-6817
pubmed: 27194761
J Clin Invest. 2008 Jul;118(7):2448-58
pubmed: 18568079
Infect Immun. 1975 May;11(5):1069-78
pubmed: 1091560
Viruses. 2020 May 28;12(6):
pubmed: 32481674
J Virol. 2003 Dec;77(23):12579-91
pubmed: 14610181
J Virol. 2015 Jul;89(14):7089-96
pubmed: 25926640